MedPath

Effect of Yashtimadhu in Asthibhagna(Fracture)

Phase 2
Conditions
Health Condition 1: M843- Stress fracture
Registration Number
CTRI/2024/08/072255
Lead Sponsor
Dr Rahul Suresh Kokare
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Patients will be selected Irrespective of caste, religion, gender and socio-economic status.

2) Patients with closed un-displaced (long bone) fractures will be Included.

Exclusion Criteria

1) Patients other than closed un-dispaced fractures are excluded.

2) Patients with known case of Diabetes Mellitus, Hypertension will be excluded.

3) Patients with pathologiacal fracture like osteoporosis will excluded.

4) Fractures requiring open reduction and internal fixation.

5) Patients with previous non-union, metastatic tumor will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in sign and symptoms of asthibhagna after ingestion of YashtimadhuTimepoint: For 25 days
Secondary Outcome Measures
NameTimeMethod
Where The Trial Group Stands In Comparison With Control GroupTimepoint: 18 Months
© Copyright 2025. All Rights Reserved by MedPath